For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral ...

However, a recent study from Sunnybrook Research Institute offers some hope. Researchers found that a type of diabetes ...

A ‘GAME-changing’ drug which could slow down Alzheimer’s disease is being considered for potential use on the NHS. The daily medication, called hydromethylthionine mesylate ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

(“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s ty ...

Before treatment, patients need a diagnosis confirmed ... based on a blood test as the enrolment criterion for dementia drug trials. That could pave the way for those blood tests, which look ...

Just 2.1 per cent of people with dementia undergo specialist investigations – such as having MRI or PET scans, which would be required for treatment with the breakthrough drugs lecanemab and ...